نتائج البحث

العلاقة: https://dx.doi.org/10.1016/S2152-2650Test(23)01256-9; Gupta V, Oh S, Devos T, Dubruille V, Catalano J, Somervaille T, et al. Clinical Outcomes With Momelotinib vs Ruxolitinib in Patients With Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-1. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2023 SEP;23:S402-S3. PubMed PMID: WOS:001062479600389. English.; http://hdl.handle.net/10541/626692Test; Clinical Lymphoma Myeloma & Leukemia

الإتاحة: https://doi.org/10.1016/S2152-2650Test(23)01256-9
http://hdl.handle.net/10541/626692Test

View record in BASE

4

دورية أكاديمية

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

المؤلفون: Mateos M. -V., Blacklock H., Schjesvold F., Oriol A., Simpson D., George A., Goldschmidt H., Larocca A., Chanan-Khan A., Sherbenou D., Avivi I., Benyamini N., Iida S., Matsumoto M., Suzuki K., Ribrag V., Usmani S. Z., Jagannath S., Ocio E. M., Rodriguez-Otero P., San Miguel J., Kher U., Farooqui M., Liao J., Marinello P., Lonial S., Nicol A., Grigoriadis G., Catalano J., LeBlanc R., Elemary M., Bahlis N., Facon T., Karlin L., Attal M., Engelhardt M., Weisel K., Mackensen A., Nagler A., Ben Yehuda D., Magen-Nativ H., Palumbo A., Cavo M., Tobinai K., Chou T., Kosugi H., Taniwaki M., Sunami K., Ando K., Ganly P., Gjertsen B., Lahuerta J., Blade J., Oriol Rocafiguera A., Mateos M., Larson S., Atanackovic D., Devarakonda S., Bitran J., Zonder J., Morganstein N., Hay M., Saylors G., Kio E., Oliff I., Kirkel D., Shtivelband M., Yuen C., Yee A., Shah J., Htut M., Raza S., Chhabra S., Stiff P., Hari P., Bank B., Malek E., Gasparetto C., Faroun Y., Kreisle W., Singhal S., Rosenblatt J., Usmani S., Lee W., Safah H., Lutzky J., Suh J., Pan D., Baron A., Manges R., Steis R., Oliveira M., Moreb J., Callander N., Anz B., Raptis A., Stampleman L., Melear J., Boyd T., Garbo L., Klein L., Shao S., Lyons R., McIntyre K., Tarantolo S., Yasenchak C., Yimer H.

المساهمون: Mateos M.-V., Blacklock H., Schjesvold F., Oriol A., Simpson D., George A., Goldschmidt H., Larocca A., Chanan-Khan A., Sherbenou D., Avivi I., Benyamini N., Iida S., Matsumoto M., Suzuki K., Ribrag V., Usmani S.Z., Jagannath S., Ocio E.M., Rodriguez-Otero P., San Miguel J., Kher U., Farooqui M., Liao J., Marinello P., Lonial S., Nicol A., Grigoriadis G., Catalano J., LeBlanc R., Elemary M., Bahlis N., Facon T., Karlin L., Attal M., Engelhardt M., Weisel K., Mackensen A., Nagler A., Ben Yehuda D., Magen-Nativ H., Palumbo A., Cavo M., Tobinai K., Chou T., Kosugi H., Taniwaki M., Sunami K., Ando K., Ganly P., Gjertsen B., Lahuerta J., Blade J., Oriol Rocafiguera A., Mateos M., Larson S., Atanackovic D., Devarakonda S., Bitran J., Zonder J., Morganstein N., Hay M., Saylors G., Kio E., Oliff I., Kirkel D., Shtivelband M., Yuen C., Yee A., Shah J., Htut M., Raza S., Chhabra S., Stiff P., Hari P., Bank B., Malek E., Gasparetto C., Faroun Y., Kreisle W., Singhal S., Rosenblatt J., Usmani S., Lee W., Safah H., Lutzky J., Suh J., Pan D., Baron A., Manges R., Steis R., Oliveira M., Moreb J., Callander N., Anz B., Raptis A., Stampleman L., Melear J., Boyd T., Garbo L.

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31327687; info:eu-repo/semantics/altIdentifier/wos/WOS:000483400400009; volume:6; issue:9; firstpage:e459; lastpage:e469; numberofpages:11; journal:THE LANCET. HAEMATOLOGY; https://hdl.handle.net/2318/1742132Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85071223893; https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026Test(19)30110-3/fulltext; https://doi.org/10.1016/s2352-3026Test(19)30110-3

الإتاحة: https://doi.org/10.1016/S2352-3026Test(19)30110-3
https://doi.org/10.1016/s2352-3026Test(19)30110-3
https://hdl.handle.net/2318/1742132Test
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026Test(19)30110-3/fulltext

View record in BASE

5

دورية أكاديمية

Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies

المؤلفون: Kulasekararaj, AG, Griffin, M, Langemeijer, S, Usuki, K, Kulagin, A, Ogawa, M, Yu, J, Mujeebuddin, A, Nishimura, JI, Lee, JW, Peffault de Latour, R, 301/302 Study Group, Latypova, A, Barcellini, W, Barraco, F, Beam, D, Bettelheim, P, Borisenkova, E, Brodsky, A, Carnley, B, Cermak, J, Chen, TY, Chew, LP, Chew, TK, Choi, CW, Choi, Y, Chung, JS, De Guibert, S, Devos, T, Dunaev, Y, Dwilewicz-Trojaczek, J, Edahiro, Y, Elykomov, I, Engelberger, MI, Pomponi, F, Fuereder, W, Fujii, N, Fujiwara, S, Galieni, P, Gaya Valls, A, Girault, S, Gomez Almaguer, D, Gonzalez Fernandez, FA, Gritsaev, S, Gunduz, E, Hantaweepant, C, Harada, H, Höglund, M, Huang, WH, Husin, A, Ikezoe, T, Ishiyama, K, Ito, Y, Jang, JH, Jo, DY, Kang, KW, Kennedy, J, Kim, HJ, Kim, JA, Kim, JS, Kimura, F, Kobune, M, Kosugi, H, Kulasekararaj, A, Lai, KM, Larratt, L, Lee, GW, Lee, JH, Lin, CC, Lukina, E, Martynova, E, Matsumura, I, Meike, G, Menosi Gualandro, SF, Minaeva, N, Mori, Y, Morita, K, Morselli Ramalho, FM, Mun, YC, Muus, P, Myasnikov, A, Naito, K, Ninomiya, H, Nogami, A, Notaro, R, Ojeda Gutierrez, E, Okada, M, Okamoto, S, Olkhovik, T, Pane, F, Paquette, R, Park, JS, Peffault de la Tour, R, Piatek, C, Piekarska, A, Pontes Reis, ML, Pospelova, T, Ptushkin, V, Roeth, A

المساهمون: DEPT OF MEDICINE

المصدر: Elements

مصطلحات موضوعية: breakthrough hemolysis, complement inhibitor, lactate dehydrogenase, paroxysmal nocturnal hemoglobinuria, ravulizumab, Antibodies, Monoclonal, Humanized, Complement C5, Complement Inactivating Agents, Hemoglobinuria, Paroxysmal, Hemolysis, Humans

العلاقة: Kulasekararaj, AG, Griffin, M, Langemeijer, S, Usuki, K, Kulagin, A, Ogawa, M, Yu, J, Mujeebuddin, A, Nishimura, JI, Lee, JW, Peffault de Latour, R, 301/302 Study Group, Latypova, A, Barcellini, W, Barraco, F, Beam, D, Bettelheim, P, Borisenkova, E, Brodsky, A, Carnley, B, Cermak, J, Chen, TY, Chew, LP, Chew, TK, Choi, CW, Choi, Y, Chung, JS, De Guibert, S, Devos, T, Dunaev, Y, Dwilewicz-Trojaczek, J, Edahiro, Y, Elykomov, I, Engelberger, MI, Pomponi, F, Fuereder, W, Fujii, N, Fujiwara, S, Galieni, P, Gaya Valls, A, Girault, S, Gomez Almaguer, D, Gonzalez Fernandez, FA, Gritsaev, S, Gunduz, E, Hantaweepant, C, Harada, H, Höglund, M, Huang, WH, Husin, A, Ikezoe, T, Ishiyama, K, Ito, Y, Jang, JH, Jo, DY, Kang, KW, Kennedy, J, Kim, HJ, Kim, JA, Kim, JS, Kimura, F, Kobune, M, Kosugi, H, Kulasekararaj, A, Lai, KM, Larratt, L, Lee, GW, Lee, JH, Lee, JH, Lee, JW, Lin, CC, Lukina, E, Martynova, E, Matsumura, I, Meike, G, Menosi Gualandro, SF, Minaeva, N, Mori, Y, Morita, K, Morselli Ramalho, FM, Mun, YC, Muus, P, Myasnikov, A, Naito, K, Ninomiya, H, Nogami, A, Notaro, R, Ojeda Gutierrez, E, Okada, M, Okamoto, S, Olkhovik, T, Pane, F, Paquette, R, Park, JS, Peffault de la Tour, R, Piatek, C, Piekarska, A, Pontes Reis, ML, Pospelova, T, Ptushkin, V, Roeth, A (2022-09-01). Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies. European Journal of Haematology 109 (3) : 205-214. ScholarBank@NUS Repository. https://doi.org/10.1111/ejh.13783Test; https://scholarbank.nus.edu.sg/handle/10635/245612Test

الإتاحة: https://doi.org/10.1111/ejh.13783Test
https://scholarbank.nus.edu.sg/handle/10635/245612Test

View record in BASE

6

دورية أكاديمية

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

المؤلفون: Usmani S. Z., Schjesvold F., Oriol A., Karlin L., Cavo M., Rifkin R. M., Yimer H. A., LeBlanc R., Takezako N., McCroskey R. D., Lim A. B. M., Suzuki K., Kosugi H., Grigoriadis G., Avivi I., Facon T., Jagannath S., Lonial S., Ghori R. U., Farooqui M. Z. H., Marinello P., San-Miguel J., Lim A., Walker T., Nicol A., Reece D., Elemary M., Boudreault Pedneault J. S., Attal M., Weisel K., Engelhardt M., Mackensen A., Quinn J., Cohen A., Magen-Nativ H., Benyamini N., Larocca A., Matsumoto M., Iida S., Ishikawa T., Kondo Y., Sunami K., Ando K., Teshima T., Chou T., Iwasaki H., Miki H., Matsumura I., Onishi Y., Izutsu K., Kizaki M., George A., Blacklock H., Simpson D., Waage A., Samoilova O., Nikitin E., Chagorova T., McDonald A., Patel M., Oriol Rocafiguera A., San Miguel Izquierdo J., Mateos M., Streetly M., Forsyth P., Jackson G., Jenkins S., Rifkin R., Yimer H., McCroskey R., Martincic D., Tarantolo S., Larson S., Faroun Y., Vaughn J., Baz R., Saylors G., Neppalli A., Raptis A., Fung H., Janosky M., Stevens D., Coleman M., Costa D., Cross S., Fanning S., Berges D. F., Harris T., Zackon I., Atanackovic D., Lee K., Oliff I., Lee W., Bensinger W., Lutzky J., Baron A., Hayek F., Kirschner E., Bharany N., Overton L., Mannem S., Harroff A., Jain S., Roque T., McIntyre K., Yasencha C. K., Houck W.

المساهمون: Usmani S.Z., Schjesvold F., Oriol A., Karlin L., Cavo M., Rifkin R.M., Yimer H.A., LeBlanc R., Takezako N., McCroskey R.D., Lim A.B.M., Suzuki K., Kosugi H., Grigoriadis G., Avivi I., Facon T., Jagannath S., Lonial S., Ghori R.U., Farooqui M.Z.H., Marinello P., San-Miguel J., Lim A., Walker T., Nicol A., Reece D., Elemary M., Boudreault Pedneault J.S., Attal M., Weisel K., Engelhardt M., Mackensen A., Quinn J., Cohen A., Magen-Nativ H., Benyamini N., Larocca A., Matsumoto M., Iida S., Ishikawa T., Kondo Y., Sunami K., Ando K., Teshima T., Chou T., Iwasaki H., Miki H., Matsumura I., Onishi Y., Izutsu K., Kizaki M., George A., Blacklock H., Simpson D., Waage A., Samoilova O., Nikitin E., Chagorova T., McDonald A., Patel M., Oriol Rocafiguera A., San Miguel Izquierdo J., Mateos M., Streetly M., Forsyth P., Jackson G., Jenkins S., Rifkin R., Yimer H., McCroskey R., Martincic D., Tarantolo S., Larson S., Faroun Y., Vaughn J., Baz R., Saylors G., Neppalli A., Raptis A., Fung H., Janosky M., Stevens D., Coleman M., Costa D., Cross S., Fanning S., Berges D.F., Harris T., Zackon I., Atanackovic D., Lee K., Oliff I., Lee W., Bensinger W., Lutzky J., Baron A., Hayek F., Kirschner E., Bharany N., Overton L.

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31327689; info:eu-repo/semantics/altIdentifier/wos/WOS:000483400400008; volume:6; issue:9; firstpage:e448; lastpage:e458; numberofpages:11; journal:THE LANCET. HAEMATOLOGY; http://hdl.handle.net/2318/1862382Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85071225647; https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026Test(19)30109-7/fulltext; https://doi.org/10.1016/s2352-3026Test(19)30109-7

الإتاحة: https://doi.org/10.1016/S2352-3026Test(19)30109-7
https://doi.org/10.1016/s2352-3026Test(19)30109-7
http://hdl.handle.net/2318/1862382Test
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026Test(19)30109-7/fulltext

View record in BASE

7

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

المؤلفون: Mateos, Maria-Victoria, Blacklock, Hilary, Schjesvold, Fredrik, Oriol, Albert, Simpson, David, George, Anupkumar, Goldschmidt, Hartmut, Larocca, Alessandra, Chanan-Khan, Asher, Sherbenou, Daniel, Avivi, Irit, Benyamini, Noam, Iida, Shinsuke, Matsumoto, Morio, Suzuki, Kenshi, Ribrag, Vincent, Usmani, Saad Z, Jagannath, Sundar, Ocio, Enrique M, Rodriguez-Otero, Paula, San Miguel, Jesus, Kher, Uma, Farooqui, Mohammed, Liao, Jason, Marinello, Patricia, Lonial, Sagar, KEYNOTE-183 Investigators, Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda S, Bitran J, Zonder J, Morganstein N, Hay M, Chanan-Khan A, Saylors G, Kio E, Oliff I, Kirkel D, Shtivelband M, Yuen C, Yee A, Shah J, Htut M, Raza S, Chhabra S, Stiff P, Hari P, Bank B, Malek E, Gasparetto C, Faroun Y, Sherbenou D, Kreisle W, Singhal S, Rosenblatt J, Usmani S, Lee W, Safah H, Lutzky J, Suh J, Pan D, Baron A, Manges R, Steis R, Oliveira M, Moreb J, Callander N, Anz B, Raptis A, Stampleman L, Melear J, Boyd T, Garbo L, Klein L, Shao S, Lyons R, McIntyre K, Tarantolo S, Yasenchak C, Yimer H.

المساهمون: Mateos, Maria-Victoria, Blacklock, Hilary, Schjesvold, Fredrik, Oriol, Albert, Simpson, David, George, Anupkumar, Goldschmidt, Hartmut, Larocca, Alessandra, Chanan-Khan, Asher, Sherbenou, Daniel, Avivi, Irit, Benyamini, Noam, Iida, Shinsuke, Matsumoto, Morio, Suzuki, Kenshi, Ribrag, Vincent, Usmani, Saad Z, Jagannath, Sundar, Ocio, Enrique M, Rodriguez-Otero, Paula, San Miguel, Jesu, Kher, Uma, Farooqui, Mohammed, Liao, Jason, Marinello, Patricia, Lonial, Sagar, KEYNOTE-183 Investigator, Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda S, Bitran J, Zonder J, Morganstein N, Hay M, Chanan-Khan A, Saylors G, Kio E, Oliff I, Kirkel D, Shtivelband M, Yuen C, Yee A, Shah J, Htut M, Raza S, Chhabra S, Stiff P, Hari P, Bank B, Malek E, Gasparetto C, Faroun Y, Sherbenou D, Kreisle W, Singhal S, Rosenblatt J, Usmani S, Lee W, Safah H, Lutzky J, Suh J, Pan D, Baron A, Manges R, Steis R, Oliveira M, Moreb J, Callander N, Anz B, Raptis A, Stampleman L, Melear J, Boyd T, Garbo L, Klein L, Shao S, Lyons R, McIntyre K, Tarantolo S, Yasenchak C, Yimer H.

المصدر: Ann Transl Med
Lancet Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

مصطلحات موضوعية: Male, medicine.medical_specialty, Pembrolizumab, Antibodies, Monoclonal, Humanized, Dexamethasone, Drug Administration Schedule, 03 medical and health sciences, Pembrolizumab, pomalidomide, dexamethasone, KEYNOTE-183, 0302 clinical medicine, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, Survival rate, Multiple myeloma, Aged, Proportional Hazards Models, Lenalidomide, Aged, 80 and over, Performance status, business.industry, Hematology, medicine.disease, Pomalidomide, Interim analysis, Progression-Free Survival, Thalidomide, Survival Rate, Myocarditis, Editorial Commentary, Treatment Outcome, Stevens-Johnson Syndrome, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, business, 030215 immunology, medicine.drug